Bambusa Therapeutics Welcomes Jonathan I. Lieber as New CFO to Propel Growth #United_States #Boston #CFO_Appointment #Bambusa_Therapeutics #Jonathan_Lieber
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialBambusa Therapeutics Begins Subcutaneous Dosing of BBT001 for Atopic Dermatitis: A Game-Changer in Treatment #United_States #Boston #Atopic_Dermatitis #Bambusa_Therapeutics #BBT001